Literature DB >> 16617020

The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity.

Liying Xu1, Shujuan Tao, Xianming Wang, Zhiying Yu, Minwei Wang, Duo Chen, Yongkui Jing, Jinhua Dong.   

Abstract

Fourteen beta-elemene derivatives containing a piperazine, a morpholine, a tetrahydropyrrole, a thiophenylethylamine, or a cyclohexamine group were synthesized. The structures of these beta-elemene derivatives were characterized with IR, 1H NMR, MS, and elemental analyses. All these derivatives had an increased anti-proliferative activity in human cervix epitheloid carcinoma HeLa, gastric carcinoma SGC-7901, and leukemia K562 cells comparing with that of beta-elemene. Among these derivatives, 13,14-bis(cis-3,5-dimethyl-1-piperazinyl)-beta-elemene (IIi), 13,14-bis[2-(2-thiophenyl)ethylamino]-beta-elemene (IIm), and 13,14-bis(cyclohexamino)-beta-elemene (IIn) were the most potent agents. IIi, IIm, and IIn inhibited K562 cell growth with an IG50 below 5 microM that was correlated with mTOR activity inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617020     DOI: 10.1016/j.bmc.2006.03.041

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  The effect of beta-elemene on alpha-tubulin polymerization in human hepatoma HepG2 cells.

Authors:  Yuqiu Mao; Jielin Zhang; Li Hou; Xiaonan Cui
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

2.  The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine.

Authors:  Yongjian Zhu; Jue Hu; Fang Shen; Hong Shen; Weiguo Liu; Jianmin Zhang
Journal:  J Neurooncol       Date:  2013-05-23       Impact factor: 4.130

3.  Radioactive synthesis and biodistribution study of beta-elemene-99mTc(CO)3 conjugates.

Authors:  Yanhong Sun; Yunfeng Ren; Hua Zhu; Yuanqing Zhang; Guifeng Liu; Chunchun Zhang; Liliang Huang; Jia Xu; Yujin Qi; Yu-Mei Shen
Journal:  J Biol Inorg Chem       Date:  2009-04-10       Impact factor: 3.358

4.  β-Elemene piperazine derivatives induce apoptosis in human leukemia cells through downregulation of c-FLIP and generation of ROS.

Authors:  Zhiying Yu; Rui Wang; Liying Xu; Siwei Xie; Jinhua Dong; Yongkui Jing
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

5.  Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.

Authors:  Feng Shi; Ji-Hui Zhao; Ying Liu; Zhi Wang; Yong-Tai Zhang; Nian-Ping Feng
Journal:  Int J Nanomedicine       Date:  2012-04-17

6.  13,14-bis(cis-3,5-dimethyl-1-piperazinyl)-β-elemene, a novel β-elemene derivative, shows potent antitumor activities via inhibition of mTOR in human breast cancer cells.

Authors:  Xiao-Fei Ding; Mao Shen; Li-Ying Xu; Jin-Hua Dong; Guang Chen
Journal:  Oncol Lett       Date:  2013-02-27       Impact factor: 2.967

7.  β -Elemene-Attenuated Tumor Angiogenesis by Targeting Notch-1 in Gastric Cancer Stem-Like Cells.

Authors:  Bing Yan; Yuqi Zhou; Shouhan Feng; Can Lv; Lijuan Xiu; Yingcheng Zhang; Jun Shi; Yongjin Li; Pinkang Wei; Zhifeng Qin
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

8.  ETME, a novel β-elemene derivative, synergizes with arsenic trioxide in inducing apoptosis and cell cycle arrest in hepatocarcinoma cells via a p53-dependent pathway.

Authors:  Zhiying Yu; Fangling Wu; Liang Chen; Qian Li; Chaojie Wang; Jinhua Dong; Song-Qiang Xie
Journal:  Acta Pharm Sin B       Date:  2014-11-22       Impact factor: 11.413

Review 9.  Biochemical significance of limonene and its metabolites: future prospects for designing and developing highly potent anticancer drugs.

Authors:  Yusif M Mukhtar; Michael Adu-Frimpong; Ximing Xu; Jiangnan Yu
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

Review 10.  Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy.

Authors:  Bingtao Zhai; Yiying Zeng; Zhaowu Zeng; Nana Zhang; Chenxi Li; Yijun Zeng; Yu You; Shuling Wang; Xiabin Chen; Xinbing Sui; Tian Xie
Journal:  Int J Nanomedicine       Date:  2018-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.